We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVR
151
Sprott Silver Miners & Physical Silver ETF
SLVR
$764M
$440K 0.12%
+7,900
New +$377K
NGD
152
DELISTED
New Gold Inc
NGD
$430K 0.12%
+49,394
New +$372K
ZM icon
153
Zoom
ZM
$31.1B
$430K 0.12%
4,988
+4,953
+14,151% +$417K
LBRDA icon
154
Liberty Broadband Class A
LBRDA
$5.33B
$414K 0.12%
8,584
MUX icon
155
McEwen Inc
MUX
$1.17B
$414K 0.12%
+22,399
New +$417K
JNJ icon
156
Johnson & Johnson
JNJ
$626B
$413K 0.12%
+2,000
New +$395K
CEPV
157
Cantor Equity Partners V
CEPV
$330M
$412K 0.12%
+40,200
New +$412K
GOOG icon
158
Alphabet (Google) Class C
GOOG
$4.19T
$406K 0.11%
1,294
-1,101
-46% -$315K
XLE icon
159
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
$404K 0.11%
+9,040
New +$403K
NLY icon
160
Annaly Capital Management
NLY
$17.4B
$393K 0.11%
17,600
+11,200
+175% +$244K
NWSA icon
161
News Corp Class A
NWSA
$15.5B
$391K 0.11%
15,000
+4,560
+44% +$120K
VKTX icon
162
Viking Therapeutics
VKTX
$3.94B
$368K 0.1%
10,464
-1,164
-10% -$41.2K
CWAN
163
DELISTED
Clearwater Analytics
CWAN
$361K 0.1%
15,000
+11,589
+340% +$232K
SQQQ icon
164
ProShares UltraPro Short QQQ
SQQQ
$1.77B
$361K 0.1%
5,278
+4,438
+528% +$314K
MHLA
165
Maiden Holdings
MHLA
$47.7M
$355K 0.1%
27,348
+2,900
+12% +$41.7K
ASTL icon
166
Algoma Steel
ASTL
$467M
$352K 0.1%
85,993
+81,463
+1,798% +$325K
TAP icon
167
Molson Coors Class B
TAP
$7.83B
$350K 0.1%
7,500
ABVX
168
Abivax
ABVX
$11.1B
$349K 0.1%
2,590
-660
-20% -$72K
SKE
169
Skeena Resources
SKE
$4.13B
$346K 0.1%
+14,600
New +$288K
FDX icon
170
FedEx
FDX
$76.3B
$342K 0.1%
1,186
+988
+499% +$259K
AOS icon
171
A.O. Smith
AOS
$8.65B
$334K 0.09%
+5,000
New +$338K
CYTK icon
172
Cytokinetics
CYTK
$10.6B
$334K 0.09%
5,260
-3,354
-39% -$209K
FIVN icon
173
FIVE9
FIVN
$2.44B
$329K 0.09%
16,450
+4,470
+37% +$94.9K
GTLB icon
174
GitLab
GTLB
$7.11B
$323K 0.09%
8,620
+2,846
+49% +$123K
CONY icon
175
YieldMax COIN Option Income Strategy ETF
CONY
$328M
$321K 0.09%
8,160
-5,410
-40% -$298K

Similar funds

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.